• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Value-based payment modifier program not associated with differences in performance program measures

byCaitlyn HuiandDeepti Shroff
December 8, 2017
in Chronic Disease, Emergency, Public Health
Reading Time: 2 mins read
HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital
Share on FacebookShare on Twitter

1. Taking into account additional patient characteristics largely influenced performance differences between practices serving high and low risk patients.

2. The value-based payment modifier program was not associated with differences in performance program measures

Evidence Rating Level: 2 (Good)

Study Rundown: Value-based payment modifier programs (VM) reward physicians for improving quality of care and reducing spending. The authors of this study aimed to determine the relationship between VM exposure and performance on quality and spending measures. Additionally, they wanted to determine whether adjusting for patient characteristics, including taking into account practices that serve high risk versus low risk patients, had an impact on the results. It was observed that when taking into account the different patient characteristics, there were large impacts on performances differences between practices. This study has several limitations. Largely, the authors could not adjust for all patient characteristic differences between practices. Factors such as education, cognition, and self-reported health status were not incorporated into the study.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: Introduction to Value-Based Payment Modifiers

RELATED REPORTS

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

Lyme disease is associated with significant health care costs

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

In-Depth [retrospective cohort]: The authors of the study assessed several performance variables, including differences in hospitalization for ambulatory care-sensitive conditions (ASCSs), readmissions, Medicare spending, and mortality between practices. The authors used cross-sectional regression discontinuity design for the first set of analyses, and compared practice performance before versus after adjusting for patient characteristics for the second set of analyses. They observed that the practices serving high-risk populations had higher races of hospitalization for ACSCs, Medicare spending, and mortality. Performance differences between practices also different significantly when taking into account other patient characteristics. Overall, the results of the study suggest that the financial incentives in the VM were not associated with significant differences in performance variables.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: healthcare costsmedicarereducing healthcare costs
Previous Post

DNA sequencing may inform diagnosis and management of kidney disease

Next Post

Pharmacomechanical thrombolysis does not lower risk of post-thrombotic syndrome: The ATTRACT trial

RelatedReports

2 Minute Medicine Rewind October 21, 2019
Public Health

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

February 16, 2026
Longer duration of antibiotic therapy does not reduce persistent symptoms in Lyme disease
Infectious Disease

Lyme disease is associated with significant health care costs

January 19, 2026
FDA-regulated clinical trials rarely report violations
All Specialties

Federal Drug Administration approves Alzheimer’s blood test for use in primary care

September 4, 2026
Public Health

Risk of financial precarity from hospitalization among Medicare beneficiaries ineligible for Medicaid

October 30, 2024
Next Post
Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Pharmacomechanical thrombolysis does not lower risk of post-thrombotic syndrome: The ATTRACT trial

Recombinant viral vector treatment sustains endogenous factor IX activity in patients with hemophilia B

Declining blood pressure in elderly associated with subcortical microinfarcts

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
  • Ecopipam reduces relapse risk in pediatric Tourette syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.